59 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Dec 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2031
Next term end
5
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Dec 2031 · Low confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Jun 2033 · High confidence
Composition and Method for Compounded Therapy
US 9,468,599
The most cited patent in this portfolio, cited by 42 later US patents, top 10% of utility patents granted in 2016 in our data. Protection runs to 2031. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear Disorders
US 9,078,853
Cited by 25 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Topical Compositions to Treat Circulatory Disorders
US 8,663,663
Renewed at every maintenance window since the 2014 grant; no more fees are due before its term ends in 2033.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Compositions and Methods for Treating an Infection (US 11,684,567) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 3 fees due Jan 4 to 18, 2027 · next Jan 4
- 1 fee due Feb 28, 2027The maintenance fee for Compounded Compositions and Methods for Treating Pain (US 11,737,975) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 3 fees due Apr 8 to 24, 2027 · next Apr 8
- 3 fees due May 17 to 28, 2027 · next May 17
- 1 fee due Jul 7, 2027The maintenance fee for Compounded Compositions and Methods for Treating Pain (US 10,525,025) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
- 1 fee due Sep 1, 2027The maintenance fee for Silicone-Based Composition for Skin Treatment (US 9,271,989) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
- 2 fees due Oct 7 to 14, 2027 · next Oct 7
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Composition and Method for Compounded Therapy | 51 in force | to Aug 2043 |
| Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear Disorders | 3 in force | to Jun 2033 |
| Topical Compositions to Treat Circulatory Disorders | 3 in force | to Jun 2033 |
| Compositions and Methods for Treating an Infection | 1 in force | to Dec 2035 |
| Compounded Transdermal Pain Management | 1 in force | to Jun 2033 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,271,989 | Silicone-Based Composition for Skin Treatment In force · Medium confidence | In force | Medium confidence | |
| US 9,468,599 | Composition and Method for Compounded Therapy In force · Low confidence | In force | Low confidence | |
| US 9,724,294 | Composition and Method for Compounded Therapy In force · Medium confidence | In force | Medium confidence | |
| US 9,962,391 | Composition and Method for Compounded Therapy In force · High confidence | In force | High confidence | |
| US 10,064,949 | Silicone-Based Composition for Skin Treatment In force · High confidence | In force | High confidence | |
| US 10,813,897 | Composition and Method for Compounded Therapy In force · Low confidence | In force | Low confidence | |
| US 11,213,500 | Composition and Method for Compounded Therapy In force · Low confidence | In force | Low confidence | |
| US 11,213,501 | Composition and Method for Compounded Therapy In force · Low confidence | In force | Low confidence | |
| US 10,105,342 | Compositions and Methods for Treating an Infection In force · Medium confidence | In force | Medium confidence | |
| US 10,617,703 | Compositions and Methods for Treating an Infection In force · High confidence | In force | High confidence |
Also on record, not counted in the 59: 4 patents ended · 12 applications pending · 30 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.